The DOH clinical costing standards, formally the Abu Dhabi Clinical Costing Standard, define how providers turn their general ledger into accurate, patient-level cost data. The accompanying clinical costing guidelines explain how to apply the Standard in practice. Together they describe a structured, six-stage pipeline that every direct patient-care facility must follow. This guide walks through each stage and points you to the tools and reading you need to get compliant.
Why the standards exist
The standards underpin Abu Dhabi's shift to value-based healthcare, where funding is tied to outcomes and efficiency rather than volume. Reliable cost data is the denominator in the value equation, so the DOH requires a consistent, auditable methodology rather than ad-hoc spreadsheets. For the regulatory backdrop, see our Abu Dhabi Clinical Costing Road Map guide.
The six-stage costing pipeline
Stage 1 · Identification of expenses for costing
Facilities must use accrual accounting, recognising expenses when incurred, not when paid. Cash-basis accounting is prohibited. Providers separate CAPEX from OPEX, capitalise and depreciate long-term assets, apportion group-level corporate overheads, and apply offsets and recoveries to arrive at the "net expense for costing".
Stage 2 · Cost ledger and SFDA mapping
Corporate cost centres are mapped to Standard Functional Delivery Areas (SFDAs), split into clinical areas (Outpatient, Inpatient, ICU, Operating Theatre, Emergency, Diagnostics) and support functions (IT, HR, Finance, Utilities, Cleaning). Direct clinical cost centres then aggregate into defined cost buckets such as Ward, ICU, Imaging, Laboratory, Physician, OR and Pharmacy.
Stage 3 · Allocation of overheads
Indirect overheads are allocated on logical causality. The standards prefer the reciprocal approach, which uses simultaneous equations to reflect the mutual support between non-clinical departments, more accurate than simple step-down methods.
Xi = Ci + Σ βji Xj
Where Xi = total reciprocal cost, Ci = direct cost, βji = proportion of service consumed
Stage 4 · Creation of costing products
Define the final cost objects, divided into:
- Patient-related products: bed days, surgical minutes, diagnostic tests, pharmaceutical dispensations.
- Non-patient "dummy" products: teaching, research, clinical trials and commercial operations.
Stage 5 · Allocation of cost to products and patients
Costs are mapped to individual encounters using a strict hierarchy:
- Actual cost: high-value identifiable items (implants, prostheses).
- Duration: time-dependent areas (bed days, OR minutes).
- Count of products: standardised activities (lab assays, scans).
- RVUs: weighting complexity where direct tracking is unavailable.
Stage 6 · Data review and reconciliation
The final stage requires physical, clinical and financial reconciliation. Patient-level totals must match the corporate general ledger, and submissions are accompanied by a reconciliation report and audited against the DOH Data Quality Standard.
Costing methods compared
| Method | Granularity | Compliance |
|---|---|---|
| Ratio of Cost to Charges (RCC) | Low: broad department averages distort encounter costs | Insufficient for patient-level mandates |
| Manual RVUs | Moderate for labour; low for clinical overheads | Vulnerable to audit findings |
| Activity-Based Costing / PLICS | High: traces actual resource consumption | Fully compliant with DOH standards |
Validate before you submit
Even a well-built costing model can fail submission on schema or reconciliation errors. Our free Abu Dhabi Clinical Costing Validator checks your XML against the current rules and the Shafafiya dictionary, flags deprecated tags, and highlights financial imbalances, entirely in your browser, so no patient data leaves your device.
Confirm your costing data meets DOH expectations.
Free, secure, client-side validation.
Open the Clinical Costing Validator →